Skip to content

The effect of an additional Braun anastomosis in patients after pancreas head resections

The effect of an additional Braun anastomosis in patients after pancreas head resections - RECOPS

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024364
Enrollment
616
Registered
2021-04-28
Start date
2022-04-08
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25.0 C25.1 K86.0 K86.1 C24.0 C24.1 C24.8 C24.9 K86.8 K86.9

Interventions

Group 1: Patients after pylorus-preserving pancreaticoduodenectomy followed by Child reconstruction and an additional Braun anastomosis between afferent and efferent loop of the gastrojejunostomy Grou

Sponsors

Klinikum Rechts der Isar der TU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with benign or malignant diseases of the pancreas, the distal bile duct and the duodenum requiring a pylorus-preserving pancreaticoduodenectomy 2. Surgical reconstruction by Child reconstruction defined as pancreaticojejunostomy followed by hepaticojejunostomy followed by duodenojejunostomy 3. Age = 18 years. 4. Ability to understand the character and individual consequences of the trial and to sign the informed consent

Exclusion criteria

Exclusion criteria: 1. Patients undergoing classical Kausch-Whipple resection 2. Patients undergoing pylorus-preserving pancreaticoduodenectomy with requirement of intraoperative arterial resection 3. Patients with pylorus-preserving pancreaticoduodenectomy with requirement of multivisceral resections 4. Laparoscopic or laparoscopic-assisted pancreatic surgery 5. Distal pancreatectomy 6. Enucleations 7. Patients after previous major GI-surgery in medical history 8. Pregnant or breast-feeding women 9. Planned re-laparotomy up to 30 days after initial surgery Emergency surgery

Design outcomes

Primary

MeasureTime frame
Incidence of clinically relevant POPF according to the current definition of the International Study group of Pancreatic surgery (ISGPS) within a postoperative period of 30 (+10) days

Secondary

MeasureTime frame
1. Incidence and severity of clinically relevant postoperative delayed gastric emptying according to ISPGS-definition (30 POD) 2. Incidence and severity of postoperative haemorrhages according to ISGPS-definition (30 POD) 3. Incidence and severity of postoperative complications according to the Clavien-Dindo classification within 30 days after surgery 5. Complication comprehensive index after operation during hospital stay 6. In-hospital, 30- and 90-day mortality rates 7. Incidence of reoperations and reinterventions 8. Incidence of anastomotic leaks of the Braun enteroenterostomy 9. Quality of life after pancreas resection (EORTC QLQ-C30) 10. Length of hospital stay (measured between day 0 of the operation and discharge) 11. Length of stay on ICU (measured from day 0 of the operation) 12. Histopathological tumor stage 13. Postoperative pain according to the Visual Analogue Scale (VAS 0-10) 14. Incidence of re-admission within the duration of the study after discharge

Countries

Germany

Contacts

Public ContactDaniel Reim

Klinik und Poliklinik für Chirurgie der TU München

daniel.reim@tum.de+498941405019

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026